MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Time perception patterns in patients with Parkinson’s disease and Alzheimer’s disease

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: We conducted this study to assess different patterns of time perception in patients with Parkinson’s disease (PD) and Alzheimer’s disease (AD). Background: Time perception…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment

    S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu (Hangzhou, China)

    Objective: We aimed to investigate the interaction between hippocampus and dopaminergic pathways in PD with mild cognitive impairment (PD-MCI). Background: Dysfunction of striatal dopaminergic neurotransmitter…
  • 2025 International Congress

    Performance Validity Test Failure Base Rates Among Presurgical Movement Disorder Patients

    J. Numerick, A. Karstens, D. Gonzalez, D. Ulrich (Chicago, USA)

    Objective: This study investigated the base rates of performance validity test (PVT) failure on neuropsychological testing in a sample of patients seeking surgical intervention (DBS/MRgFUS)…
  • 2025 International Congress

    Cognitive Changes after bilateral Thalamic VIM DBS: A Single Center Experience

    A. Boddu, L. Isaac, J. Newsom, A. Franklin, H. Schweitzer, T. Virmani, E. Petersen, J. Gess (Little Rock, USA)

    Objective: To determine post-surgical cognitive changes and their predictive factors after bilateral ventral intermediate nucleus (VIM) thalamic Deep Brain Stimulation (DBS) in people with essential…
  • 2025 International Congress

    Impact of Over-the-counter Cannabidiol Products on Cognition During the Course of Parkinson’s Disease

    A. López Lobato, D. Náfate Wences, A. Hernández Medrano, A. Cervantes Arriaga, M. Rodriguez Violante (Mexico, Mexico)

    Objective: To evaluate the association between Cannabidiol (CBD) usage and cognitive performance, measured by The Montreal Cognitive Assessment (MoCA) in people living with Parkinson's Disease…
  • 2025 International Congress

    Reliability and Validity of In-home Tele-Neuropsychological Testing in Patients with Parkinson’s Disease: A Randomized Trial

    S. Sperling, J. Dong, B. Lapin, Y. Li (Cleveland, USA)

    Objective: To assess the reliability and diagnostic validity of in-home tele-neuropsychological testing (in-home tele-npt) in individuals with Parkinson’s disease (PD). Background: Neuropsychological testing is inaccessible…
  • 2025 International Congress

    Gender Based Differences in Impulse Control Disorders within Parkinson’s Disease

    N. David, M. Steinberg, L. Higginbotham, R. Tripathi (Atlanta, USA)

    Objective: Analyze associations between gender, dopamine agonists, and levodopa doses in Parkinson’s Disease (PD) patients with Impulse control disorder (ICD). Background: ICDs, which include compulsive…
  • 2025 International Congress

    The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

    E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

    Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific…
  • 2025 International Congress

    Longitudinal MRI Study of Hippocampal Subfields Morphometry in Early Parkinson’s Disease

    T. Wu, S. Ng, T. Teo, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Chan, L. Tan, T. Welton (Singapore, Singapore)

    Objective: This prospective cohort study longitudinally investigated hippocampal subfield shape deformation and atrophy in early-stage Parkinson’s Disease (PD), using spherical harmonic-based shape analysis. Background: Hippocampal…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley